glp-1 in type 1 diabetes More people with are using drugs, study finds, despite limited evidence on safety or effectiveness Type 1 on a GLP-1

Dropped June 25, 2025, it seeks class status and jury trial

The Ozempic warning label reports: 1.5% of patients taking 0.5mg Ozempic developed cholelithiasis 0.4% of patients taking 1mg Ozempic developed cholelithiasis The updated label urges anyone who develops abdominal pain, jaundice, fever or clay-colored stools to seek a healthcare providers help right away

Buy plain, add your own fruit or honey if needed

Currently, no large-scale clinical trials have directly examined the relationship between GLP-1 agonists and acne, and these medications are not licensed for dermatological indications

The SELECT trial, as noted earlier, went a step further it tested Wegovy in overweight/obese individuals with cardiovascular disease (but without diabetes) and found a 20% reduction in heart attacks, stroke, or CV death ( [67] )

During intentional weight losswhether from calorie restriction or GLP-1 therapybile chemistry shifts and gallstone risk increases temporarily